SBIR-STTR Award

A Centrifugal Microfluidics Based Pathogen Analyzer
Award last edited on: 11/10/06

Sponsored Program
SBIR
Awarding Agency
NIH : NIAID
Total Award Amount
$691,610
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Dalibor Hodko

Company Information

Nanogen Inc

10398 Pacific Center Court
San Diego, CA 92121
   (858) 410-4600
   technicalassistance@nanogen.com
   www.nanogen.com
Location: Multiple
Congr. District: 52
County: San Diego

Phase I

Contract Number: 1R43AI052977-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
2002
Phase I Amount
$162,222
Rapid detection of biological warfare agents (BWA) in field is critical to provide appropriate countermeasures to deployment of weapons of mass destruction. The first responders in the field need instruments which will be portable (less than 10 kg), provide specific detection of a number of pathogens (desirable 810), with analysis time of ca 1-2 hours and which will not require special skills for their operation. There are numerous analyzers available for detection of pathogens in liquid samples, however, a major obstacle for their efficient use in the field is that they do not integrate sample preparation with the detection system. The methods based on analyzing DNA characteristic for each pathogen in the sample have been shown to provide most specific response and can be used when detection of multiple agents is needed. Analysis of nucleic acids requires a series of analytical steps which are difficult to integrate and automate in a field portable instrument. A unique microfluidic system is proposed which integrates pathogen separation from complex liquid samples, pathogen lysis, amplification of DNA and detection. Nanogen's commercially available electronic chip array for electrophoretic accumulation of DNA and fluoroprobes and for detection of DNA will be modified to include sample preparation step. A disposable DNA chip array will be developed with integrated sample preparation steps. The proposed method builds on developed technology and on incorporation of several innovations which will assure a quick development of a new portable field detector for detection of multiple biological agents and will be very flexible to accommodate other or new types of analytes

Phase II

Contract Number: 2R44AI052977-02
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
2005
(last award dollars: 2006)
Phase II Amount
$529,388

Potential threat of biological warfare agent (BWA) attacks as well as spread of SARS (Severe Acute Respiratory Syndrome) virus to more than two dozen countries and a recent threat of global spread of bird flu virus emphasized the need for urgent development of diagnostic systems which will be capable to rapidly recognize emergence of dangerous infectious diseases with potential epidemiologic consequences. Current DMA based portable systems for the detection of infectious agents lack multiplexing, i.e., simultaneous analysis of large number of pathogens or their genes, they do not integrate well or automate the sample preparation methods and cannot be used efficiently in the field or in point-of care applications. The microarray platform practically does not pose a limit to multiplexed detection of large number of pathogens as well as their characterization by multiple genes. The Phase I project successfully demonstrated several innovative approaches to sample preparation using centrifugal microfluidics. Three dimensional or multilayer centrifugal discs (3DCD) have been designed and fabricated which offer practically unlimited surface area for implementation of different sample preparation techniques. Several innovative tools for sample preparation in the 3DCD format have been demonstrated in the Phase I project. The overall goal of the Phase II project is to integrate these tools and develop CDs for particular assays for the detection of infectious disease and/or biological warfare agents. A DNA microarray detection platform will be integrated with the sample preparation on the 3DCD. An electronic microarray technology developed and commercialized earlier, will be used in detection. This technology assures fast DNA detection times using electrophoretically driven DNA transport and hybridization on the microarray. Specific aims of the Phase II program is to develop 3DCD technology with embedded tools for complete sample preparation and detection of several representative respiratory infectious disease pathogens as well as biological warfare agents. A fully developed technology will yield a small portable or point-of-care system with exchangeable CDs allowing choice of the pathogen detection panels including respiratory infectious disease, biological warfare agents or emergent viruses [panels.

Thesaurus Terms:
bioassay, biomedical equipment development, bioterrorism /chemical warfare, centrifugation, consumable /disposable biomedical equipment, diagnosis design /evaluation, emerging infectious disease, microarray technology, microorganism classification, rapid diagnosis DVD /CD ROM, clinical biomedical equipment, diagnosis quality /standard, fluid flow, portable biomedical equipment, virus classification bioengineering /biomedical engineering, biotechnology, high throughput technology, immunomagnetic separation, tissue /cell preparation